~~<i id='906E8D5636'><strike id='906E8D5636'><tt id='906E8D5636'><pre id='906E8D5636'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：hotspot 2025-09-27 12:47:37 - browse：12

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： For Cytokinetics, FDA rejection of heart drug would help, not hinder

explore

focus

Wikipedia

explore

knowledge

leisure time

3:08TierraYoungAllen,alsoknownas"TheSassyTrucker"onsocialmedia.CourtesyDetainedinDubaiAnAmericanTikT

WSS

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

Campaign finance charge dropped from case against Sam Bankman

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Anavex keeps shifting the goalposts in its clinical trials

Snowpack in the West is melting rapidly. Where will all that extra water go?

5 wounded, 2 critically, in Michigan shopping center shooting

explore

entertainment

explore

What does generative AI mean for health care? We asked experts

American woman, child freed after being kidnapped in Haiti last month

DIEP, the 'gold standard' of breast reconstruction, is under threat

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What to know about Virgin Galactic's 1st mission taking paying customers to space

Hepatitis C has a cure — but many Americans still lack access to it

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

After affirmative action ruling, medical educators look to 'holistic review'

HCA says smaller share of spending going to labor

focus

American TikTok star stuck in Dubai for months following rental car altercation

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Europe is fastest

Naloxone nonprofit donates 200,000 doses after FDA approval

Poland's lawmakers approve a divisive law on Russian influence

American woman, child freed after being kidnapped in Haiti last month

Wikipedia

explore

knowledge

leisure time